Protein degradation: the role of mixed-function oxidases
- PMID: 3334164
- DOI: 10.1023/a:1016484901485
Protein degradation: the role of mixed-function oxidases
Abstract
The mechanisms by which protein oxidation is mediated in the cell are of both biological and pharmacological importance. Oxidases responsible for the metabolism of xenobiotics catalyze the oxidative inactivation of select enzymes. Oxidation mediated by mixed-function oxidase (MFO) systems renders proteins more susceptible to proteolysis and, consequently, appears to be a signal for protein degradation. The mode of action of MFO systems is discussed in detail for a specific, well-characterized system--the MFO-catalyzed oxidation of glutamine synthetase (GS). Findings for this system are then generalized to help explain how other metabolic enzymes are oxidized by MFO systems. The broader consequences of oxidative mechanisms are discussed. For example, the accumulation of modified proteins during aging and in some premature aging diseases may be due in part to shifts in the relative rates of oxidation and degradation for these proteins. Further, the oxidation of key metabolic enzymes appears to be responsible for the bacteriocidal action of neutrophils. There is also some evidence that the degradation of endogenous proteins increases following ingestion of, or exposure to, agents that induce MFO activity.
Similar articles
-
Inactivation of key metabolic enzymes by mixed-function oxidation reactions: possible implication in protein turnover and ageing.Proc Natl Acad Sci U S A. 1983 Mar;80(6):1521-5. doi: 10.1073/pnas.80.6.1521. Proc Natl Acad Sci U S A. 1983. PMID: 6572914 Free PMC article.
-
Covalent modification of proteins by mixed-function oxidation: recognition by intracellular proteases.Prog Clin Biol Res. 1985;180:317-28. Prog Clin Biol Res. 1985. PMID: 2863828
-
Protein oxidation and proteolysis during aging and oxidative stress.Arch Biochem Biophys. 1989 Dec;275(2):559-67. doi: 10.1016/0003-9861(89)90402-5. Arch Biochem Biophys. 1989. PMID: 2574564
-
FAD-dependent enzymes involved in the metabolic oxidation of xenobiotics.Ann Pharm Fr. 2011 Jan;69(1):45-52. doi: 10.1016/j.pharma.2010.10.004. Epub 2010 Dec 28. Ann Pharm Fr. 2011. PMID: 21296217 Review.
-
Protein oxidation by the cytochrome P450 mixed-function oxidation system.Biochem Biophys Res Commun. 2005 Dec 9;338(1):432-6. doi: 10.1016/j.bbrc.2005.07.203. Epub 2005 Aug 29. Biochem Biophys Res Commun. 2005. PMID: 16140263 Review.
Cited by
-
Pharmacological Vitamin C Treatment Impedes the Growth of Endogenous Glutamine-Dependent Cancers by Targeting Glutamine Synthetase.Front Pharmacol. 2021 May 11;12:671902. doi: 10.3389/fphar.2021.671902. eCollection 2021. Front Pharmacol. 2021. PMID: 34054545 Free PMC article.
-
The role of pharmacokinetics in the development of biotechnologically derived agents.Clin Pharmacokinet. 1992 Dec;23(6):406-14. doi: 10.2165/00003088-199223060-00002. Clin Pharmacokinet. 1992. PMID: 1458760 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources